SBRT symposium 2019

Thursday 4 July 2019 to Friday 5 July 2019
De Boelelaan 1117, Amsterdam, 1081 HV

We are pleased to announce the program for the 6th SBRT symposium on Stereotactic and Adaptive radiotherapy. Stereotactic ablative body radiotherapy (SABR) is now essential aspect of modern multidisciplinary cancer care. With the results of SABR-COMET and other randomized trials emerging, more national guidelines are expected to incorporate SABR as a treatment option, making knowledge and availability of SABR essential for all radiation oncologists. The clinical use of adaptive radiotherapy has also increased markedly in the past 3 years, both with and without guidance using on table MR imaging. Emerging data from on-table, adaptive SABR delivery since 2016 has revealed meaningful benefits in selected patient groups, which in turn requires other departments to formulate their own strategies for implementing adaptive radiotherapy.

 

The symposium was always highly appreciated by more than 250 participants from more than 30 countries. For more information and registration, go to: www.sbrt.eu

Contact details

For any queries relating to this event please contact:

Amsterdam UMC - location VUmc
de Boelelaan 1117
1081 HV Amsterdam
Netherlands